Amicus Therapeutics, Inc. Announces Publication of BLISS Quantitative Histology Method in Archives of Pathology & Laboratory Medicine

CRANBURY, N.J., July 2, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics, Inc. (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced that a manuscript describing the Barisoni Lipid Inclusion Scoring System (BLISS) has been published in the July 2012 issue of Archives of Pathology & Laboratory Medicine. The manuscript titled, "A Novel, Quantitative Method to Evaluate GL-3 Inclusions in Renal Peritubular Capillaries by Virtual Microscopy in Patients with Fabry Disease,"1 is currently available online.